Penn Pharma
Penn Pharma has announced the completion of potent compound safety training and certification by its staff through Affygility Solutions.
Penn Pharma officially opened a new purpose-built contained manufacturing facility in September 2013 and the training and subsequent certification of its staff was a critical factor milestone to achieve.
Affygility Solutions was selected to complete the training certification based on its specific expertise in potent compound safety. Affygility Solutions also offered a flexible webinar format that allowed Penn Pharma staff to attend from multiple global locations.
The training was extremely comprehensive and included: Introduction to Potent Compound Safety, Toxicology, Industrial Hygiene, Banding and Control Strategies and the Manufacturing of Highly Potent Compounds.
This comprehensive programme, along with the flexibility of training, made Affygility Solutions the perfect partner for Penn Pharma.
Penn Pharma COO Mark Dean Netscher commented: “We are extremely pleased to have our staff complete the potent compound safety training certification process. This is an important component of our continued commitment to employee safety and operational excellence in Penn as we continue to demonstrate leadership of the handling, development and manufacturing of potent products in our contained manufacturing facility.”
Penn Pharma, www.pennpharm.com.